Cargando…

Cognitive effects of adjunctive perampanel for partial‐onset seizures: A randomized trial

OBJECTIVE: Assess cognitive effects of adjunctive perampanel in adolescents. METHODS: In this double‐blind study (ClinicalTrials.gov identifier: NCT01161524), patients aged 12 to <18 years with partial‐onset seizures despite receiving 1–3 antiepileptic drugs were randomized (2:1) to perampanel or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meador, Kimford J., Yang, Haichen, Piña‐Garza, Jesus Eric, Laurenza, Antonio, Kumar, Dinesh, Wesnes, Keith A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Full‐length Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785606/ https://www.ncbi.nlm.nih.gov/pubmed/26724782 http://dx.doi.org/10.1111/epi.13279

Ejemplares similares

Open‐label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (4 to <12 years) with inadequately controlled focal seizures or generalized tonic‐clonic seizures
por: Fogarasi, Andras, et al.
Publicado: (2020)

Assessment of the long‐term efficacy and safety of adjunctive perampanel in tonic‐clonic seizures: Analysis of four open‐label extension studies
por: Rektor, Ivan, et al.
Publicado: (2020)

Long-term safety of perampanel and seizure outcomes in refractory partial-onset seizures and secondarily generalized seizures: Results from phase III extension study 307
por: Krauss, Gregory L, et al.
Publicado: (2014)

Psychiatric and behavioral adverse events in randomized clinical studies of the noncompetitive AMPA receptor antagonist perampanel
por: Ettinger, Alan B., et al.
Publicado: (2015)

Impact of perampanel on pharmacokinetics of concomitant antiepileptics in patients with partial‐onset seizures: pooled analysis of clinical trials
por: Majid, Oneeb, et al.
Publicado: (2016)

Perampanel efficacy and safety by gender: Subanalysis of phase III randomized clinical studies in subjects with partial seizures
por: Vazquez, Blanca, et al.
Publicado: (2015)

Once-daily USL255 as adjunctive treatment of partial-onset seizures: Randomized phase III study
por: Chung, Steve S, et al.
Publicado: (2014)

Value of Perampanel as Adjunctive Treatment for Partial-Onset Seizures in Epilepsy: Cost-Effectiveness and Budget Impact Analysis
por: Zhang, Donger, et al.
Publicado: (2021)

Efficacy and safety of adjunctive perampanel in patients with focal seizures or generalized tonic‐clonic seizures: Post hoc analysis of Phase II and Phase III double‐blind and open‐label extension studies in India
por: Mehndiratta, Man M., et al.
Publicado: (2021)

Profile of perampanel and its potential in the treatment of partial onset seizures
por: Rheims, Sylvain, et al.
Publicado: (2013)

Perampanel and pregnancy
por: Vazquez, Blanca, et al.
Publicado: (2021)

Efficacy and safety of adjunctive perampanel 4 mg/d for the treatment of focal seizures: A pooled post hoc analysis of four randomized, double‐blind, phase III studies
por: Steinhoff, Bernhard J., et al.
Publicado: (2020)

Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial-onset seizures: Results of a phase III, double-blind, randomized, placebo-controlled trial
por: Sperling, Michael R, et al.
Publicado: (2015)

Clinical efficacy of perampanel for partial-onset and primary generalized tonic–clonic seizures
por: Besag, Frank MC, et al.
Publicado: (2016)

Seizure reduction with fluoxetine in an adult woman with Dravet syndrome
por: Meador, Kimford J.
Publicado: (2014)

Efficacy and safety of perampanel monotherapy in patients with focal‐onset seizures with newly diagnosed epilepsy or recurrence of epilepsy after a period of remission: The open‐label Study 342 (FREEDOM Study)
por: Yamamoto, Takamichi, et al.
Publicado: (2020)

Efficacy and Tolerability of Perampanel as Adjunctive Therapy in Chinese Patients With Focal-Onset Seizures: An Observational, Prospective Study
por: Zhang, Ranran, et al.
Publicado: (2021)

Perampanel in the management of partial-onset seizures: a review of safety, efficacy, and patient acceptability
por: Schulze-Bonhage, Andreas, et al.
Publicado: (2015)

Perampanel efficacy and tolerability with enzyme-inducing AEDs in patients with epilepsy
por: Gidal, Barry E., et al.
Publicado: (2015)

Evaluation of perampanel as monotherapy for focal seizures: Experience from open-label extension studies
por: Kwan, Patrick, et al.
Publicado: (2017)

The efficacy and safety of adjunctive perampanel for the treatment of refractory focal‐onset seizures in patients with epilepsy: A meta‐analysis
por: Li, Yiming, et al.
Publicado: (2022)

Real‐world analysis of hospitalizations in patients with epilepsy and treated with perampanel
por: Faught, Edward, et al.
Publicado: (2021)

Adjunctive perampanel for glioma-associated epilepsy()
por: Dunn-Pirio, Anastasie M., et al.
Publicado: (2018)

Clinical utility of adjunctive retigabine in partial onset seizures in adults
por: Rejdak, Konrad, et al.
Publicado: (2012)

Efficacy of Retigabine in Adjunctive Treatment of Partial Onset Seizures in Adults
por: Splinter, Michele Y.
Publicado: (2013)

Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy: A randomized trial
por: French, Jacqueline A., et al.
Publicado: (2015)

Anti-Seizure Activity of 1-Adamantane Carboxylic Acid in Common Experimental Seizure Models: Role of Benzodiazepine-GABA(A) Receptors
por: Ghanbari, Elham, et al.
Publicado: (2021)

Two-year seizure reduction in adults with medically intractable partial onset epilepsy treated with responsive neurostimulation: Final results of the RNS System Pivotal trial
por: Heck, Christianne N, et al.
Publicado: (2014)

Perampanel: What is its Place in the Management of Partial Onset Epilepsy?
por: Ledingham, David R. M., et al.
Publicado: (2013)

Incidence of seizure exacerbation and seizures reported as adverse events during adjunctive treatment with eslicarbazepine acetate: A pooled analysis of three Phase III controlled trials
por: Carreño, Mar, et al.
Publicado: (2017)

Lacosamide adjunctive therapy for partial-onset seizures: a meta-analysis
por: Sawh, Sonja C., et al.
Publicado: (2013)

A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial‐onset seizures in daily clinical practice: The VITOBA study
por: Runge, Uwe, et al.
Publicado: (2015)

Perampanel in real‐world clinical care of patients with epilepsy: Interim analysis of a phase IV study
por: Wheless, James, et al.
Publicado: (2020)

Cost-effectiveness of perampanel as an adjunctive treatment for uncontrolled focal seizures in pediatric patients: a Chinese perspective
por: Hu, Yani, et al.
Publicado: (2022)

Pregabalin as adjunctive therapy in adult and pediatric patients with generalized tonic‐clonic seizures: A randomized, placebo‐controlled trial
por: Driscoll, Joseph, et al.
Publicado: (2021)

First add‐on perampanel for focal‐onset seizures: An open‐label, prospective study
por: Kim, Ji Hyun, et al.
Publicado: (2019)

Real‐world experience with direct brain‐responsive neurostimulation for focal onset seizures
por: Razavi, Babak, et al.
Publicado: (2020)

New drug classes for the treatment of partial onset epilepsy: focus on perampanel
por: Shih, Jerry J, et al.
Publicado: (2013)

Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial‐onset seizures: A randomized historical‐control phase III study based in North America
por: Sperling, Michael R., et al.
Publicado: (2015)

Long‐term safety of adjunctive cenobamate in patients with uncontrolled focal seizures: Open‐label extension of a randomized clinical study
por: French, Jacqueline A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qgoep2jhejj7tbvkr7golj1cl5